Epidemiology and Clinical Features of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus. Literature Review
Open Access
- 12 January 2024
- journal article
- review article
- Published by Synapse, LLC in The Russian Archives of Internal Medicine
- Vol. 13 (6) , 436-448
Abstract
Hypertension and type 2 diabetes mellitus are often combined and mutually enhance the adverse effect on vascular and renal prognosis. Hypertension is present in about 50 % of patients with type 2 diabetes, and diabetes, in turn, is detected in about 20 % of people with hypertension. The risk of developing hypertension in patients with type 2 diabetes is 2-2.5 times higher than in people without diabetes; the presence of hypertension increases the risk of type 2 diabetes by the same number of times. Hypertension and diabetes mutually burden each other: on the one hand, the presence of hypertension significantly increases the likelihood of developing diabetic macro- and microvascular complications (including diabetic nephropathy and retinopathy); on the other hand, type 2 diabetes, as a classic independent cardiovascular risk factor, increases the risk of complications inherent in hypertension by about 2 times Careful treatment of diabetes with maintenance of target values of glycemia for a long time may be associated with a decrease in the likelihood of developing hypertension by 24 % compared with less adequate control of glycemia. Hypertension in type 2 diabetes may have a number of features that distinguish such patients from the general population of people with hypertension. Such features include a higher proportion of isolated systolic hypertension and resistant hypertension, certain types of circadian rhythm disorders of blood pressure (categories “non-dipper” and “night-peaker”), frequent combination with albuminuria, frequent high salt sensitivity and volume-dependent nature of hypertension, and others.Keywords
This publication has 38 references indexed in Scilit:
- Preventing β-Cell Loss and Diabetes With Calcium Channel BlockersDiabetes, 2012
- Novedades en hipertensión arterial y diabetes mellitusRevista Española de Cardiología (English Edition), 2012
- Cardiovascular Events During Differing Hypertension Therapies in Patients With DiabetesJACC, 2010
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic NephropathyJournal of the American Society of Nephrology, 2009
- Determinants of New-Onset Diabetes Among 19,257 Hypertensive Patients Randomized in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm and the Relative Influence of Antihypertensive MedicationDiabetes Care, 2008
- A Meta-Analysis of 94,492 Patients With Hypertension Treated With Beta Blockers to Determine the Risk of New-Onset Diabetes MellitusThe American Journal of Cardiology, 2007
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathyNature Clinical Practice Nephrology, 2006
- Renin-angiotensin system inhibition prevents type 2 diabetes mellitusDiabetes & Metabolism, 2004
- Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic HypertensionNew England Journal of Medicine, 1999